Cargando…
Surgery in the age of biologics
Since the introduction of the first anti-tumor necrosis factor antibodies in the late 1990s, biologic therapy has revolutionized the medical treatment of patients with inflammatory bowel disease (IBD). Nevertheless, surgery continues to play a significant role in treating IBD patients. Rates of inte...
Autores principales: | Wong, Daniel J, Roth, Eve M, Feuerstein, Joseph D, Poylin, Vitaliy Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454839/ https://www.ncbi.nlm.nih.gov/pubmed/30976420 http://dx.doi.org/10.1093/gastro/goz004 |
Ejemplares similares
-
Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
por: Poylin, Vitaliy Y., et al.
Publicado: (2022) -
Radiation Proctitis: Current Strategies in Management
por: Do, Nhue L., et al.
Publicado: (2011) -
Changing approaches to rectal prolapse repair in the elderly
por: Poylin, Vitaliy, et al.
Publicado: (2013) -
EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC
por: Young, Karen, et al.
Publicado: (2022) -
The impact of surgeon choices on costs associated with uncomplicated minimally invasive colectomy: you are not as important as you think
por: Tillou, John, et al.
Publicado: (2018)